The announcement comes as coronavirus cases among children surge in the United States and other parts of the world.
After developing a coronavirus vaccine in record time, the German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.
The Biovac Institute reached a deal with Pfizer to prepare and deliver vaccine doses for the continent. It comes amid an increase of cases in Africa, where just 2% of the population have received a first dose.
As the world continues to battle the effects of the coronavirus pandemic, health experts and several pharmaceutical companies have come up with vaccines to reduce the effects. Oxford-AstraZeneca vaccine has given a significant boost to the global fight and here are five key things to know about the controversial vaccine.
Gov. Zulum facilitates enrolment of 1,163 IDP children in school, Twitter drops by 8.5% in early trading over Trump's ban and more
Here are a few reasons to pick up a copy of The Guardian on Tuesday. Find these stories and much more when you grab a copy of The Guardian on Tuesday.
25 Dec 2020
We're not superheroes, we are scientists, BioNTech CEO Ugur Sahin has told DW. In an exclusive interview, the scientist explains how the firm will respond to a new virus strain and why he has not been vaccinated yet.
23 Dec 2020
It is "highly likely" that BioNTech's coronavirus vaccine works against the variant detected in the UK, the company's CEO has said. If necessary, the German firm could also adapt the vaccine within six weeks.
23 Dec 2020
The decision by European Medicines Agency may allow countries to begin vaccinating before the end of the year. The vaccine's approval was widely expected, as EU nations grapple with a worsening coronavirus second wave.
UK issues allergy warning over Pfizer-BioNTech vaccine, I have no case to answer, Maina tells Court and more
9 Dec 2020
Here are a few reasons to pick up a copy of The Guardian on Thursday. Find these stories and much more when you grab a copy of The Guardian on Thursday.
5 Dec 2020
Pfizer and BioNTech have lodged their COVID-19 vaccine with the European Medicines Agency for conditional approval. The companies have already taken similar steps in the US and UK.
17 Nov 2020
Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.
15 Nov 2020
A vaccine jointly developed by German company BioNTech and US firm Pfizer has proven to be 90% effective at preventing COVID-19 infections, according to phase 3 trials.